People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...

At the Type B end-of-Phase 2 MS meeting with the U.S. Food and Drug Administration, FDA aligned with Clene acknowledging the limitations of the Expanded Disability Status Scale and expressed openness ...

By Dennis Thompson HealthDay ReporterTHURSDAY, Sept. 25, 2025 (HealthDay News) — A growing number of Americans appear to be ...

There’s a good chance that you haven’t heard about a rare condition called chromhidrosis. In a nutshell, the person afflicted with the disease produces colored sweat, from yellow to green, even red ...

Epilepsy Action Council of Management forms the policy of the charity and is responsible for overseeing sound management of ...

Health and Human Services Secretary Robert F. Kennedy Jr. stirred up major concerns and considerable speculation earlier this year when he announced the administration would release a report ...

A landmark placebo-controlled trial shows shunting improves walking and reduces falls in idiopathic normal-pressure ...

Scientists turned patients' skin and blood cells into stem cells, and grew 3D brain model to study the brain signal patterns ...

Thursday 25 September 2025People with Disability Australia (PWDA) welcomes the National Disability Insurance Agency's ...

A growing number of U.S. adults—particularly those under 40—are reporting serious challenges with memory, concentration and decision-making, according to a new study published in the September 24, ...

A recent study reveals a concerning rise in cognitive difficulties among U.S. adults, particularly in memory, concentration, ...

He said this after President Donald Trump told the United Nations climate change is not real and criticised countries ...